Cephalexin Capsule
Product Images NDC 65862-018

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cephalexin (NDC 65862-018). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cephalexin-fig1 (Cephalexin Fig1)

This is a prescription drug with NDC 65862-018-20 used for treating infections. It comes in the form of capsules containing Cephalexin, and each capsule contains 250 mg Cephalexin monohydrate. The recommended dosage for an adult is one capsule every 6 hours. In case of severe infection, the dose may be increased not more than 4g per day. It is necessary to read the accompanying literature before usage, and the container must be tightly closed and stored at a temperature ranging between 20° to 25°C (68° to 77°F). The drug must be kept out of the reach of children, and the container should be dispensed tightly in a light-resistant container. The drug is made in India and distributed by Aurobindo Pharma USA, Inc.*

FDA Label Image

Cephalexin-fig2 (Cephalexin Fig2)

FDA Label Image

Structure (Cephalexin Str)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.